NCT04774952 2025-04-15Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsRevolution Medicines, Inc.Phase 1 Completed58 enrolled
NCT02164461 2024-05-20Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical CancerAdvaxis, Inc.Phase 1 Completed12 enrolled 18 charts
NCT02759588 2023-01-05GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian CancerGenelux CorporationPhase 1/2 Completed46 enrolled
NCT03562897 2022-07-06Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial CancerCatalysis SLPhase 2 Completed40 enrolled
NCT00326885 2018-10-17Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant AscitesNeovii BiotechPhase 2 Completed32 enrolled 12 charts